Moderna Asks FDA to Clear Its Covid-19 Vaccine for Young Children

México Noticias Noticias

Moderna Asks FDA to Clear Its Covid-19 Vaccine for Young Children
México Últimas Noticias,México Titulares
  • 📰 WSJ
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 63%

Moderna asked the FDA to authorize its Covid-19 vaccine for children 6 months to 5 years. If regulators agree, vaccinations could begin by summer.

Shot has been tested for kids aged 6 months to 5 years, a group not yet eligible for vaccination in the U.S.

Children under five in the U.S. aren’t yet eligible for a Covid-19 vaccine after efforts to get the shots to market have hit setbacks. WSJ’s Peter Loftus explains what we know about the vaccines and when they might become available. Photo composite: Todd JohnsonModerna Inc. has asked U.S. health regulators to authorize the use of its Covid-19 vaccine in children ages 6 months to 5 years old.

The company said Thursday that it had submitted the request after a study showed the shot safely induced immune responses in the young age group.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

WSJ /  🏆 98. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Pfizer Asks FDA to Authorize Covid-19 Booster for 5- to 11-Year-OldsPfizer Asks FDA to Authorize Covid-19 Booster for 5- to 11-Year-OldsPfizer Inc. and partner BioNTech SE said earlier this month that a third shot safely generated a strong immune response in the youngsters.
Leer más »

Pfizer requests FDA authorization for Covid-19 booster for kids 5 through 11Pfizer requests FDA authorization for Covid-19 booster for kids 5 through 11Pfizer and BioNTech said Tuesday that they have submitted an application to the US Food and Drug Administration for emergency use authorization of a booster dose of Covid-19 vaccine for children 5 through 11.
Leer más »

Pfizer asks FDA to clear COVID-19 booster shot for children ages 5 to 11Pfizer asks FDA to clear COVID-19 booster shot for children ages 5 to 11Pfizer asked U.S. regulators for emergency-use authorization of a booster shot of its COVID-19 vaccine in children ages 5 to 11.
Leer más »

Moderna to ask FDA to authorize Covid-19 vaccine for young kidsModerna to ask FDA to authorize Covid-19 vaccine for young kidsThe request comes a month after the drug company signaled its two-dose regimen generated immune protection in the youngest children comparable to young adults.
Leer más »

Moderna Asks FDA to Approve Its COVID-19 Shot for Kids Under 6Moderna Asks FDA to Approve Its COVID-19 Shot for Kids Under 6Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer.
Leer más »

Moderna asks FDA to authorize first COVID-19 vaccine for very young childrenModerna asks FDA to authorize first COVID-19 vaccine for very young childrenThe company says a low-dose version of its vaccine triggers an immune response in children ages 6 months to less than 6 years equivalent to what has protected older children and adults.
Leer más »



Render Time: 2025-03-05 05:29:31